Veryan in the Media

An interview with Professor Thomas Zeller, MD

The Director of the Department of Angiology at Universitaets-Herzzentrum talks data on renal denervation, drug-eluting balloons, and other recent trials.

3D Helical Stent Twelve Month Data Suggest Correlation between Stented Vessel Curvature and Primary Patency

Data presented here today during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 show that a stent with unique three-dimensional helical geometry, BioMimics 3D™, developed by Veryan Medical Ltd...

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

PARIS, France—A “3D” helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results...

Clinical Data Supports Efficacy of New 3-D Stent

On May 21, Veryan Medical Ltd. presented data during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 in Paris, France, on its Biomimics 3D stent. A recent trial has demonstrated safety and promising...

Veryan Medical: Improving Stent Performance with 3-D, Helical Geometry

One of the most interesting emerging competitors in the peripheral vascular stenting space is UK-based Veryan Medical Ltd. The privately held, venture funded company has developed a unique yet straightforward method of producing...

Imperial Innovations Set to Increase Investment in Veryan Medical

The technology transfer, incubation and venture investment company Imperial Innovations, Veryan's largest investor with a 44.3% shareholding, is proposing to increase its investment in the company, in order to help fund future growth...